14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 1.332 38 days ( -58.59 % )
Last Price $7.20 -2.57 %
High/ Low $7.02 - $7.50 30.77%
Chg 7 Days 29.26 % $5.57 $7.20
Chg 30 Days 42.29 % $5.06 $7.20
Chg 12 mos 275.00 % $1.92 $7.20
Trend - 3 mos 29.70 % Width: 52.45 %
Trend - 12 mos 49.08 % Width: 150.46 %
Pred. range - 3 mos $6.31 - $9.62 -12.35 % - 33.62 %
Pred. range - 12 mos $4.40 - $11.03 -38.83 % - 53.22 %
Short MA avg 3 mos Buy Apr 25, 2024 - 9 days
Long MA avg 3 mos Buy Mar 13, 2024 - 39 days
Short/Long MA avg 3 mos Buy Mar 20, 2024 - 34 days
Short MA avg 12 mos Buy Apr 25, 2024 - 9 days
Long MA avg 12 mos Buy Dec 21, 2023 - 94 days
Short/Long MA avg 12 mos Buy Dec 28, 2023 - 90 days
Pivot Short Sell May 06, 2024 - 2 days
Bollinger Buy Apr 26, 2024 - 8 days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Black Diamond Therapeutics Inc.

Black Diamond Therapeutics. Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 driver mutations. The company is also developing BDTX-1535, a brain-penet... BDTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT